Erdinç Ertürk

1.4k total citations
82 papers, 1.1k citations indexed

About

Erdinç Ertürk is a scholar working on Endocrinology, Diabetes and Metabolism, Epidemiology and Nephrology. According to data from OpenAlex, Erdinç Ertürk has authored 82 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Endocrinology, Diabetes and Metabolism, 17 papers in Epidemiology and 15 papers in Nephrology. Recurrent topics in Erdinç Ertürk's work include Pituitary Gland Disorders and Treatments (16 papers), Parathyroid Disorders and Treatments (11 papers) and Thyroid Cancer Diagnosis and Treatment (8 papers). Erdinç Ertürk is often cited by papers focused on Pituitary Gland Disorders and Treatments (16 papers), Parathyroid Disorders and Treatments (11 papers) and Thyroid Cancer Diagnosis and Treatment (8 papers). Erdinç Ertürk collaborates with scholars based in Türkiye, United States and United Kingdom. Erdinç Ertürk's co-authors include Şazi İmamoğlu, Ariel L. Barkan, Craig A. Jaffe, Sinem Kıyıcı, Canan Ersoy, Cevdet Duran, Ercan Tuncel, Canan Ersoy, E. Tuncel and Ferah Budak and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Erdinç Ertürk

68 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erdinç Ertürk Türkiye 18 458 174 167 163 132 82 1.1k
Semra Çeti̇nkaya Türkiye 18 585 1.3× 360 2.1× 239 1.4× 128 0.8× 98 0.7× 158 1.3k
Mesut Özkaya Türkiye 18 281 0.6× 209 1.2× 160 1.0× 91 0.6× 108 0.8× 70 1.1k
Penelope Trimpou Sweden 18 370 0.8× 96 0.6× 256 1.5× 103 0.6× 59 0.4× 50 893
Duke Appiah United States 18 241 0.5× 100 0.6× 105 0.6× 153 0.9× 129 1.0× 81 1.2k
Min Jae Kang South Korea 21 283 0.6× 161 0.9× 142 0.9× 87 0.5× 70 0.5× 69 1.0k
Marie-Louise Bartelink Netherlands 12 317 0.7× 63 0.4× 248 1.5× 173 1.1× 129 1.0× 34 1.2k
Charlotte Landbo Tofteng Denmark 15 501 1.1× 212 1.2× 100 0.6× 76 0.5× 202 1.5× 24 1.4k
Tânia Weber Furlanetto Brazil 21 624 1.4× 164 0.9× 232 1.4× 53 0.3× 91 0.7× 58 1.4k
Christos S. Katsouras Greece 21 267 0.6× 137 0.8× 492 2.9× 219 1.3× 297 2.3× 111 1.5k
Ahmad Hazem United States 9 382 0.8× 150 0.9× 216 1.3× 143 0.9× 36 0.3× 14 1.2k

Countries citing papers authored by Erdinç Ertürk

Since Specialization
Citations

This map shows the geographic impact of Erdinç Ertürk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erdinç Ertürk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erdinç Ertürk more than expected).

Fields of papers citing papers by Erdinç Ertürk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erdinç Ertürk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erdinç Ertürk. The network helps show where Erdinç Ertürk may publish in the future.

Co-authorship network of co-authors of Erdinç Ertürk

This figure shows the co-authorship network connecting the top 25 collaborators of Erdinç Ertürk. A scholar is included among the top collaborators of Erdinç Ertürk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erdinç Ertürk. Erdinç Ertürk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Çalapkulu, Murat, Özen Öz Gül, Soner Cander, et al.. (2022). Co-existence of Papillary and Medullary Thyroid Carcinoma: Reports of Three Cases. Journal of College of Physicians And Surgeons Pakistan. 32(8). S156–S158.
3.
Cander, Soner, et al.. (2022). Retrospective Evaluation of the Efficiency of Therapeutic Plasmapheresis in Thyrotoxic Patients. SHILAP Revista de lepidopterología. 4. 93–99. 1 indexed citations
4.
Cander, Soner, et al.. (2021). Pituitary Stalk Interruption Syndrome: A Case Report. SHILAP Revista de lepidopterología. 3(Supplement 1). 96–97. 1 indexed citations
5.
Çalapkulu, Murat, Özen Öz Gül, Soner Cander, et al.. (2020). Control of Refractory Hypercalcemia with Denosumab in a Case of Metastatic Parathyroid Carcinoma. Journal of College of Physicians And Surgeons Pakistan. 30(7). 757–759. 4 indexed citations
6.
Gül, Özen Öz, et al.. (2020). May Hemocytometer Parameters Be a Biomarker in Distinguishing between Adrenal Adenomas and Carcinomas and in Prognosis of Adrenocortical Carcinomas?. SHILAP Revista de lepidopterología. 1 indexed citations
7.
Çalapkulu, Murat, Özen Öz Gül, Soner Cander, et al.. (2019). An Unusual Case of Ectopic Prolactinoma in the Clivus. Endocrinology research and practice.. 23(3). 191–194. 1 indexed citations
8.
Cander, Soner, et al.. (2017). Causes of elevated parathyroid hormone levels in postmenopausal women. The European Research Journal. 1 indexed citations
9.
Cander, Soner, et al.. (2017). Adrenocortical carcinoma: Single center experience. SHILAP Revista de lepidopterología. 43(4). 462–469. 11 indexed citations
10.
Gül, Özen Öz, et al.. (2014). Clinical Management of Insulinomas: A Single Institutions Experience. SHILAP Revista de lepidopterología. 18(3). 79–83. 1 indexed citations
11.
Ertürk, Erdinç, et al.. (2013). Klinefelter Syndrome. SHILAP Revista de lepidopterología. 17(3). 63–67.
12.
Gül, Özen Öz, Sinem Kıyıcı, Canan Ersoy, et al.. (2011). Effect of sitagliptin monotherapy on serum total ghrelin levels in people with type 2 diabetes. Diabetes Research and Clinical Practice. 94(2). 212–216. 13 indexed citations
13.
Kıyıcı, Sinem, Soner Cander, Canan Ersoy, et al.. (2009). Rapid preparation of patients with hyperthyroidism for thyroidectomy. 20. 1 indexed citations
14.
Duran, Cevdet, E. Tuncel, Canan Ersoy, et al.. (2009). The investigation of the efficacy of insulin glargine on glycemic control when combined with either repaglinide or acarbose in obese Type 2 diabetic patients. Journal of Endocrinological Investigation. 32(1). 69–73. 9 indexed citations
15.
Altan, Lale, et al.. (2007). Brown tumor of the sacral spine in a patient with low-back pain. Rheumatology International. 28(1). 77–81. 22 indexed citations
16.
Ersoy, Canan, et al.. (2006). İnsülin Kullanan Tip 2 Diabetes Mellituslu Hastalarda Diyabet Eğitimi ve Metabolik Kontrol. DergiPark (Istanbul University). 32(2). 43–47. 1 indexed citations
17.
Webb, Susan M., A. Colao, Philippe Caron, et al.. (2006). A European prospective real-life observational study of Quality of Life in patients with acromegaly. 11. 2 indexed citations
18.
Ertürk, Erdinç, et al.. (2003). Sigarayı bırakma tedavisinin sonuçları. 4(1). 73–77.
19.
Göksel, Tuncay, et al.. (2002). Sigara ile ilişkili ciddi akciğer hastalığı olanların sigara içen yakınlarında sigara bırakma tedavisinin başarısı. 3(3). 248–252. 2 indexed citations
20.
Ertürk, Erdinç, Craig A. Jaffe, & Ariel L. Barkan. (1998). Evaluation of the Integrity of the Hypothalamic-Pituitary-Adrenal Axis by Insulin Hypoglycemia Test1. The Journal of Clinical Endocrinology & Metabolism. 83(7). 2350–2354. 153 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026